Publications by authors named "Phillip Lam"

Failure of central nervous system (CNS) axons to regenerate after injury results in permanent disability. Several molecular neuro-protective and neuro-regenerative strategies have been proposed as potential treatments but do not provide the directional cues needed to direct target-specific axon regeneration. Here, we demonstrate that applying an external guidance cue in the form of electric field stimulation to adult rats after optic nerve crush injury was effective at directing long-distance, target-specific retinal ganglion cell (RGC) axon regeneration to native targets in the diencephalon.

View Article and Find Full Text PDF
Article Synopsis
  • Giant cell myocarditis (GCM) and cardiac sarcoidosis have similar symptoms and tissue characteristics, leading to questions about their relationship on the inflammatory cardiomyopathy spectrum.
  • The case involves a patient who experienced cardiogenic shock linked to GCM, confirmed by biopsy.
  • After a heart transplant, the patient was diagnosed with sarcoidosis using 18-fluorodeoxyglucose PET imaging and another biopsy.
View Article and Find Full Text PDF

Background: Renin-angiotensin system (RAS) inhibitors at higher target doses reduce the risk of death in patients with heart failure with reduced ejection fraction (HFrEF). Less is known about their effectiveness in octogenarians, the examination of which was the objective of this study.

Methods: Of the 32,964 veterans ≥ 80 years with HFrEF (ejection fraction ≤ 40%) receiving RAS inhibitors, 6655 received them at target doses.

View Article and Find Full Text PDF

Background: National heart failure guidelines recommend quadruple therapy with renin-angiotensin system inhibitors, beta-blockers, mineralocorticoid receptor antagonists, and sodium-glucose cotransporter 2 inhibitors for patients with heart failure with reduced ejection fraction (HFrEF), most of whom also receive loop diuretics. However, the guidelines are less clear about the safe approaches to discontinuing older drugs whose decreasing or residual benefit is less well understood. The objective of this study was to examine whether digoxin can be safely discontinued in patients with HFrEF receiving beta-blockers.

View Article and Find Full Text PDF

Heart transplant (HT) recipients are more frequently reaching childbearing age given improvement in median survival and outcomes after HT. Although most pregnancies in HT recipients have favorable outcomes, poor fetal outcomes and maternal complications such as hypertensive disorders of pregnancy are more common in HT recipients than in the general population. In this review, we summarize the current evidence to guide the management of pregnancy in HT recipients.

View Article and Find Full Text PDF

The impact of cardiac resynchronization therapy (CRT) in patients receiving durable left ventricular assist device (LVAD) implantation remains unclear and there is no consensus regarding postoperative management. We sought to determine the impact of postoperative management of CRT on clinical outcomes following LVAD implantation. A total of 789 patients underwent LVAD implantation at our institution from 2007 to 2022 including 195 patients (24.

View Article and Find Full Text PDF

Aims: Heart failure (HF) is a clinical syndrome with no definitive diagnostic tests. HF registries are often based on manual reviews of medical records of hospitalized HF patients identified using International Classification of Diseases (ICD) codes. However, most HF patients are not hospitalized, and manual review of big electronic health record (EHR) data is not practical.

View Article and Find Full Text PDF

Aims: According to the Kidney Disease: Improving Global Outcomes (KDIGO) guideline, the definition of chronic kidney disease (CKD) requires the presence of abnormal kidney structure or function for >3 months with implications for health. CKD in patients with heart failure (HF) has not been defined using this definition, and less is known about the true health implications of CKD in these patients. The objective of the current study was to identify patients with HF who met KDIGO criteria for CKD and examine their outcomes.

View Article and Find Full Text PDF
Article Synopsis
  • Understanding noncardiovascular comorbidities and geriatric syndromes is crucial for managing elderly patients with heart failure, particularly those over 80 years old.
  • Small studies have shown links between heart failure and significant geriatric issues, including cognitive and functional decline.
  • By considering these factors, healthcare professionals can create tailored treatment plans that improve adherence and overall health outcomes for older adults with heart failure.
View Article and Find Full Text PDF
Article Synopsis
  • * A study of 789 LVAD patients showed that 12.7% experienced early VAs, with certain risk factors like end-stage renal disease, preoperative electrical storms, and prior defibrillator therapy linked to this complication.
  • * Early VAs were found to significantly increase the risk of death within 30 days post-surgery, while they did not affect long-term survival compared to those without VAs.
View Article and Find Full Text PDF
Article Synopsis
  • Sudden cardiac arrest (SCA) significantly contributes to deaths in patients with heart failure and preserved ejection fraction (HFpEF), accounting for about 25% of fatalities in key studies.
  • A study analyzing data from over 2.9 million hospitalizations found that SCA occurred in 1.48% of cases, primarily affecting older adults, with notable predictors being certain cardiac conditions and liver disease.
  • The outcomes for patients experiencing SCA were significantly worse than for those who did not, showing higher mortality rates, more major bleeding complications, and increased need for interventions like percutaneous coronary procedures.
View Article and Find Full Text PDF

Metastatic bony disease is a significant health issue, with approximately 700,000 new cases annually that tend to metastasize to bones. The proximal femur in the appendicular skeleton is commonly affected. Our study aimed to investigate mortality rates and hospital stay duration in patients with pathologic proximal femur fractures treated with either intramedullary nailing or arthroplasty within the Veterans Health Administration system.

View Article and Find Full Text PDF

Awake patients in ventricular fibrillation is a phenomenon limited to patients who are mechanically supported. We describe a cohort of patients supported by left ventricular assist devices (LVADs) presenting to the emergency department (ED) at a high-volume LVAD center while in awake ventricular fibrillation (VF)/ventricular tachycardia (VT). Among 175 patients reviewed, a total of 19 LVAD patients presented to the ED in awake VF/VT between December 2015 and July 2021.

View Article and Find Full Text PDF
Article Synopsis
  • Guideline-directed medical therapy (GDMT) is a key treatment for heart failure with reduced ejection fraction (HFrEF) and includes four main drug classes: renin-angiotensin system inhibitors, evidence-based β-blockers, mineralocorticoid inhibitors, and sodium glucose cotransporter 2 inhibitors.
  • Research supports GDMT's effectiveness, showing improved clinical outcomes when these drug classes are used together.
  • Despite its benefits, GDMT is often underutilized due to a lack of understanding about how to start and properly adjust these medications in both hospital and outpatient settings.
View Article and Find Full Text PDF
Article Synopsis
  • Renin-angiotensin system inhibitors can enhance outcomes for patients with heart failure and reduced ejection fraction (HFrEF), but their effectiveness in those with advanced kidney disease was less understood.
  • In a study involving 1,582 patients with HFrEF and severe kidney issues, researchers analyzed the effects of starting ACE inhibitors or ARBs on patient outcomes.
  • The results indicated that patients who started these medications experienced better outcomes regarding heart failure readmissions and overall mortality, suggesting that these drugs may be beneficial for this specific patient group.
View Article and Find Full Text PDF

Background: Implantable cardioverter-defibrillators (ICDs) improve outcomes in patients with heart failure (HF) with left ventricular ejection fraction (LVEF) ≤35%. Less is known about whether outcomes varied between the 2 noninvasive imaging modalities used to estimate LVEF-2-dimensional echocardiography (2DE) and multigated acquisition radionuclide ventriculography (MUGA)-which use different principles (geometric vs count-based, respectively).

Objective: The purpose of this study was to examine whether the effect of ICD on mortality in patients with HF and LVEF ≤35% varied on the basis of LVEF measured by 2DE or MUGA.

View Article and Find Full Text PDF

Purpose Of Review: Cardiogenic shock (CS) is a complex clinical entity that continues to carry a high risk of mortality. The landscape of CS management has changed with the advent of several temporary mechanical circulatory support (MCS) devices designed to provide hemodynamic support. It remains challenging to understand the role of different temporary MCS devices in patients with CS, as many of these patients are critically ill, requiring complex care with multiple MCS device options.

View Article and Find Full Text PDF

Heart failure (HF) is a risk factor for incident stroke. However, less is known about the independent nature of this association and to what extent various baseline characteristics may mediate this risk. Of the 5,795 community-dwelling adults aged ≥65 years in the Cardiovascular Health Study, 5,448 were free of baseline stroke, of whom 229 had baseline HF.

View Article and Find Full Text PDF

Background: National heart failure (HF) guidelines recommend that in patients with HF with preserved ejection fraction (EF;HFpEF) and hypertension, systolic blood pressure (SBP) should be maintained below 130 mmHg. The objective of the study is to examine the association between initiation of anti-hypertensive drugs and outcomes in patients with HFpEF with persistent hypertension.

Methods: Of the 8873 hospitalized patients with HFpEF (EF ≥50%) with a history of hypertension without renal failure in Medicare-linked OPTIMIZE-HF, 3315 had a discharge SBP ≥130 mmHg, of whom 1971 were not receiving anti-hypertensive drugs, thiazides and calcium channel blockers, before hospitalization.

View Article and Find Full Text PDF

Background: Few treatments exist for the cognitive symptoms of schizophrenia. Pharmacological agents resulting in glutamate N-methyl-d-aspartate (NMDA) receptor hypofunction, such as MK-801, mimic many of these symptoms and disrupt neural activity. Recent evidence suggests that deep brain stimulation (DBS) of the medial septal nucleus (MSN) can modulate medial prefrontal cortex (mPFC) and hippocampal activity and improve spatial memory.

View Article and Find Full Text PDF

Background: Continuous infusion of ambulatory inotropic therapy (AIT) is increasingly used in patients with end-stage heart failure (HF). There is a paucity of data concerning the concomitant use of beta-blockers (BB) in these patients.

Methods: We retrospectively reviewed all patients discharged from our institution on AIT.

View Article and Find Full Text PDF

Background: Acute decompensation of heart failure (HF) is often marked by fluid retention, and weight loss is a marker of successful diuresis. We examined the relationship between in-hospital weight loss and post-discharge outcomes in patients with HF.

Methods: We conducted a propensity score-matched study of 8830 patients hospitalized for decompensated HF in the Medicare-linked Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) registry, in which 4415 patients in the weight-loss group and 4415 patients in the no-weight-loss group were balanced on 75 baseline characteristics.

View Article and Find Full Text PDF
Article Synopsis
  • Beta-blockers have been shown to improve outcomes in patients with heart failure, particularly those with reduced ejection fraction (HFrEF), but their effectiveness in older nursing home residents remains less clear.
  • A study analyzed data from nearly 6,500 hospitalized patients aged 65 and over with HFrEF to assess the impact of beta-blockers on mortality and heart failure readmissions, specifically comparing outcomes between nursing home residents and other patients.
  • The findings indicated that beta-blocker use was linked to reduced all-cause mortality in older adults, but there was no significant difference in heart failure readmissions, regardless of whether patients were admitted from nursing homes or not.
View Article and Find Full Text PDF